Renin-Angiotensin System Blockade Improves Cardiac Indices in Acromegaly Patients

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Experimental and clinical endocrinology & diabetes

• Publication date

  2017-02-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0042-123710PMID 28166592PMCID PMC6193280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management

  2018cited by this paper
• Normal values for cardiovascular magnetic resonance in adults and children

  2015cited by this paper
• Inhibitory effect of candesartan cilexetil on left ventricular remodeling after myocardial infarction.

  2006cited by this paper
• Cardiovascular function in acromegaly.

  2003cited by this paper
• Growth hormone and the heart

  2001cited by this paper
• Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

  2000cited by this paper
• Angiotensin‐converting enzyme (ACE) inhibition attenuates insulin‐like growth factor‐I (IGF‐I) induced cardiac fibroblast proliferation

  2000cited by this paper
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

  1999cited by this paper
• Early treatment with low-dose enalapril after acute myocardial infarction: An equilibrium radionuclide angiographic study

  1997cited by this paper
• Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.

  1995cited by this paper
• Growth hormone and the heart.

  1994cited by this paper
• Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril on the Long‐term Progression of Left Ventricular Dilatation in Patients With Asymptomatic Systolic Dysfunction

  1993cited by this paper
• Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study.

  1993cited by this paper
• Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril on the Long‐term: Progression of Left Ventricular Dysfunction in Patients With Heart Failure

  1992cited by this paper
• Aldosterone in Acromegaly

  1984cited by this paper

• An Overview of Cardiovascular Risk in Pituitary Disorders

  2024cites this paper
• Effects of acromegaly treatment on left ventricular systolic function assessed by speckle tracking echocardiography in relation to sex differences: results from a prospective single center study

  2023cites this paper
• (Cardiovascular complications in acromegaly)

  2022cites this paper
• Kardiovaskulárne komplikácie akromegálie ( Cardiovascular complications in acromegaly )

  2022cites this paper
• Heart failure as a manifestation of acromegaly.

  2020cites this paper
• Cardiac resynchronization therapy improves heart failure in one patient with acromegaly-induced cardiomyopathy: a case report

  2019cites this paper
• Hypertension and Acromegaly.

  2019cites this paper
• Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management

  2018cites this paper